This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser.
Print Document
Reports
Cover
Statements
Condensed Balance Sheets (unaudited)
Condensed Balance Sheets (unaudited) (Parenthetical)
Condensed Statement of Operations and Comprehensive Loss (unaudited)
Condensed Statement of Operations and Comprehensive Loss (unaudited) (Parenthetical)
Condensed Statement of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) (unaudited)
Condensed Statement of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) (unaudited) (Parenthetical)
Condensed Statements of Cash Flows (unaudited)
Condensed Statements of Cash Flows (unaudited) (Parenthetical)
Reports
Description of Business
Summary of Significant Accounting Policies
Related Party Transactions
Fair Value Measurements
Marketable Securities
Balance Sheet Details
Commitment and Contingencies
Convertible Preferred Stock and Stockholders’ Deficit
Equity Incentive Plan and Stock-Based Compensation
Net loss per share
Income Taxes
Segment Reporting
Subsequent Events
Insider Trading Arrangements
Accounting Policies
Summary of Significant Accounting Policies (Policies)
Tables
Fair Value Measurements (Tables)
Marketable Securities (Tables)
Balance Sheet Details (Tables)
Commitment and Contingencies (Tables)
Convertible Preferred Stock and Stockholders’ Deficit (Tables)
Equity Incentive Plan and Stock-Based Compensation (Tables)
Net loss per share (Tables)
Segment Reporting (Tables)
Details
Description of Business - Organization (Details)
Description of Business - Liquidity and Capital Resources (Details)
Summary of Significant Accounting Policies (Details)
Related Party Transactions - Hengrui Pharmaceuticals Exclusive License Agreement (Details)
Related Party Transactions - Other Related Party Transactions (Details)
Fair Value Measurements (Details)
Marketable Securities - Components (Details)
Marketable Securities - Narrative (Details)
Balance Sheet Details - Accrued Expenses and Other Current Liabilities (Details)
Commitment and Contingencies - Hengrui License Agreement – Contingent Obligations (Details)
Commitment and Contingencies - Operating Lease (Details)
Commitment and Contingencies - Future Minimum Payment (Details)
Convertible Preferred Stock and Stockholders’ Deficit - Convertible Preferred Stock, Narrative (Details)
Convertible Preferred Stock and Stockholders’ Deficit - Common Stock, Narrative (Details)
Convertible Preferred Stock and Stockholders’ Deficit - Common Stock Reserved for Issuance (Details)
Equity Incentive Plan and Stock-Based Compensation - Narrative (Details)
Equity Incentive Plan and Stock-Based Compensation - Stock Option Activity (Details)
Equity Incentive Plan and Stock-Based Compensation - Stock-Based Compensation Expense (Details)
Equity Incentive Plan and Stock-Based Compensation - Fair Value Assumptions of Options (Details)
Equity Incentive Plan and Stock-Based Compensation - Restricted Stock Activity (Details)
Net loss per share - Computation (Details)
Net loss per share - Antidilutive Securities (Details)
Segment Reporting - Narrative (Details)
Segment Reporting - Schedule (Details)
All Reports